MX382815B - Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas. - Google Patents

Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas.

Info

Publication number
MX382815B
MX382815B MX2018004175A MX2018004175A MX382815B MX 382815 B MX382815 B MX 382815B MX 2018004175 A MX2018004175 A MX 2018004175A MX 2018004175 A MX2018004175 A MX 2018004175A MX 382815 B MX382815 B MX 382815B
Authority
MX
Mexico
Prior art keywords
applications
preparation
derivative
medicines
oxa
Prior art date
Application number
MX2018004175A
Other languages
English (en)
Other versions
MX2018004175A (es
Inventor
Binqiang Feng
Feng He
Mingxun He
Piaoyang Sun
Tao Liu
Weikang Tao
Xin Li
Yang Chen
Original Assignee
Jiangsu Hengrui Medicine Co
Shanghai hengrui pharmaceutical co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co, Shanghai hengrui pharmaceutical co ltd filed Critical Jiangsu Hengrui Medicine Co
Publication of MX2018004175A publication Critical patent/MX2018004175A/es
Publication of MX382815B publication Critical patent/MX382815B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se relaciona con un derivado oxa espiro, un método de preparación del mismo, y aplicaciones del mismo en medicinas. Particularmente, la presente invención se relaciona con un derivado oxa espiro representado por la fórmula (I), un método de preparación del mismo, y una composición farmacéutica que comprende el derivado, las aplicaciones del mismo como un agonista del receptor MOR, y aplicaciones en la preparación de fármacos para tratar y/o evitar los dolores y los dolores relacionados con las enfermedades. Los grupos de sustitución en la fórmula (I) son los mismos que las definiciones en la especificación.
MX2018004175A 2015-10-15 2016-09-30 Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas. MX382815B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510665328 2015-10-15
CN201511032876 2015-12-31
PCT/CN2016/101064 WO2017063509A1 (zh) 2015-10-15 2016-09-30 氧杂螺环类衍生物、其制备方法及其在医药上的应用

Publications (2)

Publication Number Publication Date
MX2018004175A MX2018004175A (es) 2018-06-06
MX382815B true MX382815B (es) 2025-03-12

Family

ID=58517778

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018004175A MX382815B (es) 2015-10-15 2016-09-30 Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas.

Country Status (16)

Country Link
US (1) US10442793B2 (es)
EP (1) EP3354649B1 (es)
JP (1) JP6824502B2 (es)
KR (1) KR102703513B1 (es)
CN (1) CN107001347B (es)
AU (1) AU2016339404B2 (es)
CA (1) CA3000761C (es)
DK (1) DK3354649T3 (es)
ES (1) ES2772689T3 (es)
HU (1) HUE048032T2 (es)
MX (1) MX382815B (es)
PL (1) PL3354649T3 (es)
PT (1) PT3354649T (es)
RU (1) RU2733373C2 (es)
TW (1) TWI727981B (es)
WO (1) WO2017063509A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3610875T (lt) * 2017-04-14 2020-11-25 Jiangsu Hengrui Medicine Co., Ltd. Opioido (mor) agonisto druska, jo fumarato druskos i kristalinė forma ir jos gavimo būdas
CN108727347B (zh) * 2017-04-14 2020-06-16 江苏恒瑞医药股份有限公司 一种阿片样物质受体(mor)激动剂的晶型及其制备方法
TW201836606A (zh) * 2017-04-14 2018-10-16 大陸商江蘇恆瑞醫藥股份有限公司 一種mor激動劑與kor激動劑聯合在製備緩解和/或治療疼痛的藥物中的用途
CN115124520A (zh) * 2017-07-04 2022-09-30 四川海思科制药有限公司 阿片受体激动剂及其应用
CN109516982B (zh) 2017-09-18 2022-08-23 上海华汇拓医药科技有限公司 μ-阿片受体激动剂及其制备方法和在医药领域的应用
CA3076395A1 (en) * 2017-09-28 2019-04-04 Jiangsu Hengrui Medicine Co., Ltd. Method for preparing oxaspirocycle derivative, and intermediate thereof
CN111148515B (zh) * 2017-10-13 2022-07-19 山东绿叶制药有限公司 2,6-二氧杂螺[4,5]癸烷类衍生物、其制备方法及其在医药上的应用
MX2020005660A (es) * 2017-12-06 2020-08-20 Jiangsu Hengrui Medicine Ltd Uso de un agonista de kor en combinacion con un agonista de mor para preparar medicamentos para tratar el dolor.
WO2019205983A1 (zh) * 2018-04-28 2019-10-31 四川科伦博泰生物医药股份有限公司 氧杂螺环类化合物及其制备方法和用途
CN108424372B (zh) * 2018-05-11 2021-08-10 浙江华贝药业有限责任公司 2,2,2-三氟-n-[(s)-4-羰基四氢萘-1-基]-乙酰胺的纯化工艺
TW202015678A (zh) * 2018-05-14 2020-05-01 大陸商江蘇恆瑞醫藥股份有限公司 一種mor受體激動劑醫藥組成物
CN108707086B (zh) * 2018-05-15 2021-08-10 浙江华贝药业有限责任公司 一种(1s,4s)-n-(4-羟基四氢萘-1-基)叔丁氧基碳酰胺的纯化工艺
WO2020073985A1 (zh) * 2018-10-12 2020-04-16 江苏恒瑞医药股份有限公司 一种阿片样物质受体(mor)激动剂的结晶形式及制备方法
WO2020073984A1 (zh) * 2018-10-12 2020-04-16 江苏恒瑞医药股份有限公司 一种阿片样物质受体(mor)激动剂的结晶形式及制备方法
CN112334465B (zh) * 2019-01-17 2024-06-11 上海海雁医药科技有限公司 三环取代的氧杂螺环衍生物、其制法与医药上的用途
CN111662284B (zh) * 2019-03-06 2021-08-10 上海海雁医药科技有限公司 双杂环取代的氧杂螺环衍生物、其制法与医药上的用途
WO2021027304A1 (zh) * 2019-08-14 2021-02-18 上海海雁医药科技有限公司 镇痛化合物、其制法与医药上的用途
EP4092031A4 (en) 2020-01-17 2024-02-21 Shanghai Haiyan Pharmaceutical Technology Co., Ltd. AZABICYCLIC SUBSTITUTED OXASPIRO DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND ITS MEDICAL USE
CN114269751B (zh) * 2020-01-17 2024-04-16 上海海雁医药科技有限公司 光学纯的氧杂螺环取代的吡咯并吡唑衍生物、其制法与医药上的用途
CN113214264B (zh) * 2020-01-21 2022-08-09 上海海雁医药科技有限公司 二氢吡咯并五元杂芳基取代的氧杂螺环衍生物、其制法与医药上的用途
US20230101735A1 (en) 2020-01-22 2023-03-30 Jiangsu Hengrui Medicine Co., Ltd. Anti-trop-2 antidody-exatecan analog conjugate and medical use thereof
CN114075141B (zh) * 2020-08-20 2025-02-25 上海致根医药科技有限公司 阿片受体“偏向性”配体、其制备方法及其在医药上的应用
CN114539257B (zh) * 2020-11-24 2023-08-11 江苏恒瑞医药股份有限公司 嘧啶二酮类螺环衍生物、其制备方法及其在医药上的应用
EP4265604B1 (en) 2020-12-29 2026-04-01 Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Oxaspiro substituted pyrrolopyrazole derivative, intermediate thereof, and preparation method therefor
EP4361154A4 (en) * 2021-07-13 2025-06-18 Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Pharmaceutically acceptable salt of a Mor receptor agonist, polymorph thereof, and use thereof
AU2022322838B2 (en) * 2021-08-02 2024-12-12 Jiangsu Nhwa Pharmaceutical Co., Ltd Oxaspiro derivative, and preparation method therefor and use thereof
CN117263956A (zh) * 2022-01-19 2023-12-22 天地恒一制药股份有限公司 阿片受体激动剂及其制备方法和用途
CN116589451B (zh) * 2022-02-11 2024-07-09 成都硕德药业有限公司 一种6-氧杂螺[4,5]癸烷类化合物的新晶型、用途及其制备方法
CN117624138A (zh) * 2022-08-29 2024-03-01 江苏恒瑞医药股份有限公司 一种氧杂螺环类衍生物的可药用盐、晶型及制备方法
CN119894904B (zh) * 2022-09-27 2025-12-30 上海枢境生物科技有限公司 一种含螺环类衍生物的盐、晶型及其制备方法和应用
KR20250137614A (ko) 2023-01-18 2025-09-18 상하이 센후이 메디슨 컴퍼니 리미티드 테트라히드로-1-나프틸아민 및 이의 유도체의 제조 방법
WO2026026772A1 (zh) * 2024-07-30 2026-02-05 上海枢境生物科技有限公司 氧杂螺环类衍生物的富马酸盐晶型及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160534B1 (es) 1999-12-30 2002-04-16 Vita Invest Sa Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
DE10044649A1 (de) 2000-09-08 2002-07-04 Gruenenthal Gmbh Substituierte 4-Phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
DE102006033109A1 (de) 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
US7999107B2 (en) * 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
WO2009018169A1 (en) 2007-07-27 2009-02-05 Auspex Pharmaceuticals, Inc. Substituted cyclohexanols
CA2779252C (en) * 2008-10-31 2015-05-05 Pain Therapeutics, Inc. Filamin a-binding anti-inflammatory analgesic
WO2010148191A2 (en) 2009-06-17 2010-12-23 Board Of Regents, The University Of Texas System Compositions and methods for cyclofructans as separation agents
ME02754B (me) * 2011-03-23 2018-01-20 Trevena Inc Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
HUE029070T2 (en) 2011-12-12 2017-02-28 Gruenenthal Gmbh (1R, 4R) -6'-Fluoro (N, N-Dimethyl- and N-methyl) -4-phenyl-4 ', 9'-dihydro-3'H-spiro [cyclohexane-1,1'- pyrano- [3,4, B] indole] -4-amine
SI2880037T1 (sl) 2012-08-03 2019-04-30 Johnson Matthey Public Limited Company Postopek za pripravo oksikodona
CA2891334C (en) 2012-11-13 2021-10-19 Array Biopharma Inc. Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain

Also Published As

Publication number Publication date
RU2018115569A (ru) 2019-11-18
PT3354649T (pt) 2020-02-03
CA3000761C (en) 2024-02-13
KR20180063251A (ko) 2018-06-11
EP3354649A4 (en) 2018-08-08
KR102703513B1 (ko) 2024-09-06
CN107001347A (zh) 2017-08-01
TWI727981B (zh) 2021-05-21
AU2016339404A1 (en) 2018-05-24
CA3000761A1 (en) 2017-04-20
RU2733373C2 (ru) 2020-10-01
RU2018115569A3 (es) 2020-01-20
DK3354649T3 (da) 2020-02-24
JP2018534257A (ja) 2018-11-22
ES2772689T3 (es) 2020-07-08
PL3354649T3 (pl) 2020-07-27
MX2018004175A (es) 2018-06-06
EP3354649A1 (en) 2018-08-01
CN107001347B (zh) 2019-09-24
HUE048032T2 (hu) 2020-05-28
BR112018006448A2 (pt) 2018-10-16
US10442793B2 (en) 2019-10-15
TW201718558A (zh) 2017-06-01
WO2017063509A1 (zh) 2017-04-20
US20180297988A1 (en) 2018-10-18
AU2016339404B2 (en) 2020-08-27
EP3354649B1 (en) 2019-12-04
JP6824502B2 (ja) 2021-02-03

Similar Documents

Publication Publication Date Title
MX2018004175A (es) Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas.
CL2019001744A1 (es) Derivados de benzoxazol como inmunomoduladores.
CO2018004124A2 (es) Compuestos heterocíclicos
NI201700096A (es) Derivados de 4h-pirrol[3, 2-c]piridin-4-ona
CL2018003323A1 (es) Piridinas sustituidas con heteroarilo y métodos de uso.
MX372914B (es) Derivado de piperidina y metodo de preparacion y uso farmaceutico del mismo.
CO2017011851A2 (es) Compuestos novedosos
CL2018001685A1 (es) Compuestos heterociclicos como inmuno moduladores.
CL2018000542A1 (es) Nuevos derivados de fenoximetilo.
EA201890126A1 (ru) Новые бициклические производные, способ их получения и фармацевтические композиции, содержащие их
ECSP17081744A (es) Nuevos derivados hidroxiéster,un proceso para su preparación y composiciones farmacéuticas que los contienen
MX378194B (es) Compuestos organicos.
NI201600144A (es) Derivados de quinoxalina utiles como moduladores del fgfr cinasa
BR112016012146A2 (pt) Compostos derivados de aminopiridina como inibidores quinase da família tam, composição farmacêutica compreendendo ditos compostos e uso terapêutico dos mesmos
EA201892838A1 (ru) Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их
SV2018005760A (es) Derivados de aminotiazol utiles como agentes antiviricos
MX2015012456A (es) Compuestos heterociclicos y usos de los mismos.
MX374452B (es) Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades.
BR112016022069A2 (pt) Composto, composição farmacêutica, e, uso de um composto
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
UY36175A (es) 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas
MX387235B (es) Derivados de pirazolopiridina y su uso en terapia
UY35906A (es) Novedosos derivados de bencimidazol como ligandos de ep4
EA201600124A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
CR20160460A (es) Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados